The antioxidant effect of estrogen and Selective Estrogen Receptor Modulators in the inhibition of osteocyte apoptosis in vitro

Bone

Volumn 40, Issue 3, 2007, Pages 674-684

  Mann, Val ^a   Huber, Christene ^a   Kogianni, Giolanta ^a   Collins, Frances ^b   Noble, Brendon ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Antioxidant; Apoptosis; Estrogen; Osteocyte; SERMs

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 17ALPHA ESTRADIOL; 6 HYDROXY 2 (4 HYDROXYPHENYL) 3 [4 [2 (1 PYRROLIDINYL)ETHOXY]BENZOYL] BENZO[B]THIOPHENE; 6 HYDROXY 2 (4 HYDROXYPHENYL) 3 [4 [2 (1 PYRROLIDINYL)ETHOXY]BENZOYL]BENZO[B]THIOPHENE; ALPHA TOCOPHEROL; ESTRADIOL; ESTROGEN; ESTROGEN DERIVATIVE; ETHINYLESTRADIOL; FULVESTRANT; HYDROGEN PEROXIDE; MESTRANOL; QUINESTROL; RALOXIFENE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL STRAIN HEK293; CHEMICAL STRUCTURE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOCYTE; OXIDATIVE STRESS; STEREOISOMERISM;

ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; ESTROGENS; HUMANS; MAP KINASE SIGNALING SYSTEM; OSTEOCYTES; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELECTIVE ESTROGEN RECEPTOR MODULATORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33846813959     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.10.014     Document Type: Article

References (44)

1. Ammann P., and Rizzoli R. Bone strength and its determinants. Osteoporos Int. 14 Suppl. 3 (2003) S13-S18
2. Ferretti J.L., Cointry G.R., Capozza R.F., and Frost H.M. Bone mass, bone strength, muscle-bone interactions, osteopenias and osteoporoses. Mech. Ageing Dev. 124 (2003) 269-279
3. van Lenthe G.H., and Huiskes R. How morphology predicts mechanical properties of trabecular structures depends on intra-specimen trabecular thickness variations. J. Biomech. 35 (2002) 1191-1197
4. Reilly G.C., Knapp H.F., Stemmer A., Niederer P., and Knothe M.L. Tate Investigation of the morphology of the lacunocanalicular system of cortical bone using atomic force microscopy. Ann. Biomed. Eng. 29 (2001) 1074-1081
5. Aarden E.M., Burger E.H., and Nijweide P.J. Function of osteocytes in bone. J. Cell Biochem. 55 (1994) 287-299
6. Power J., Noble B.S., Loveridge N., Bell K.L., Rushton N., and Reeve J. Osteocyte lacunar occupancy in the femoral neck cortex: an association with cortical remodeling in hip fracture cases and controls. Calcif. Tissue Int. 69 (2001) 13-19
7. Qiu S., Rao D.S., Palnitkar S., and Parfitt A.M. Relationships between osteocyte density and bone formation rate in human cancellous bone. Bone 31 (2002) 709-711
8. Marotti G., Farneti D., Remaggi F., and Tartari F. Morphometric investigation on osteocytes in human auditory ossicles. Anat. Anz. 180 (1998) 449-453
9. Hernandez C.J., Majeska R.J., and Schaffler M.B. Osteocyte density in woven bone. Bone 35 (2004) 1095-1099
10. Frost H.M. A brief review for orthopedic surgeons: fatigue damage (microdamage) in bone (its determinants and clinical implications). J. Orthop. Sci. 3 (1998) 272-281
11. Burr D.B. Remodeling and the repair of fatigue damage. Calcif. Tissue Int. 53 Suppl. 1 (1993) S75-S80
12. Dunstan C.R., Somers N.M., and Evans R.A. Osteocyte death and hip fracture. Calcif. Tissue Int. 53 Suppl. 1 (1993) S113-S116
13. Kogianni G., Mann V., Ebetino F., Nuttall M., Nijweide P., Simpson H., et al. Fas/CD95 is associated with glucocorticoid-induced osteocyte apoptosis. Life Sci. 75 (2004) 2879-2895
14. Noble B.S., Peet N., Stevens H.Y., Brabbs A., Mosley J.R., Reilly G.C., et al. Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. Am. J. Physiol. Cell Physiol. 284 (2003) C934-C943
15. Tomkinson A., Reeve J., Shaw R.W., and Noble B.S. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J. Clin. Endocrinol. Metab 82 (1997) 3128-3135
16. Kikuyama A., Fukuda K., Mori S., Okada M., Yamaguchi H., and Hamanishi C. Hydrogen peroxide induces apoptosis of osteocytes: involvement of calcium ion and caspase activity. Calcif. Tissue Int. 71 (2002) 243-248
17. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000) 239-247
18. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222 (1999) 236-245
19. Behl C., Widmann M., Trapp T., and Holsboer F. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216 (1995) 473-482
20. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J., et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51 (1997) 535-541
21. Tomkinson A., Gevers E.F., Wit J.M., Reeve J., and Noble B.S. The role of estrogen in the control of rat osteocyte apoptosis. J. Bone Miner. Res. 13 (1998) 1243-1250
22. Pietras R.J., and Szego C.M. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265 (1977) 69-72
23. Castoria G., Barone M.V., Di Domenico M., Bilancio A., Ametrano D., Migliaccio A., et al. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 18 (1999) 2500-2510
24. Pedram A., Razandi M., Aitkenhead M., Hughes C.C., and Levin E.R. Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J. Biol. Chem. 277 (2002) 50768-50775
25. Riggs B.L., and Hartmann L.C. Selective estrogen-receptor modulators-mechanisms of action and application to clinical practice. N. Engl. J. Med. 348 (2003) 618-629
26. Collishaw S. Mosley JTCRJaNBS. A selective estrogen receptor modulator (SERM) inhibits osteocyte apoptosis during estrogen loss. Implications for bone quality maintenance. J. Bone Miner. Res. 18 Suppl. 2 (2003) S293 [Ref. Type: Generic]
27. Kato Y., Windle J.J., Koop B.A., Mundy G.R., and Bonewald L.F. Establishment of an osteocyte-like cell line, MLO-Y4. J. Bone Miner. Res. 12 (1997) 2014-2023
28. Lee D., Long S.A., Murray J.H., Adams J.L., Nuttall M.E., Nadeau D.P., et al. Potent and selective nonpeptide inhibitors of caspases 3 and 7. J. Med. Chem. 44 (2001) 2015-2026
29. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273 (1998) 18623-18632
30. Kousteni S., Bellido T., Plotkin L.I., O'Brien C.A., Bodenner D.L., Han L., et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104 (2001) 719-730
31. Dauvois S., White R., and Parker M.G. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J. Cell Sci. 106 Pt 4 (1993) 1377-1388
32. Kahlert S., Nuedling S., van Eickels M., Vetter H., Meyer R., and Grohe C. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J. Biol. Chem. 275 (2000) 18447-18453
33. Thomas P., Pang Y., Filardo E.J., and Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146 (2005) 624-632
34. Gu G., Hentunen T.A., Nars M., Harkonen P.L., and Vaananen H.K. Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis. Apoptosis. 10 (2005) 583-595
35. Green P.S., Bishop J., and Simpkins J.W. 17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells. J. Neurosci. 17 (1997) 511-515
36. Behl C. Oestrogen as a neuroprotective hormone. Nat. Rev., Neurosci. 3 (2002) 433-442
37. Basu S., Michaelsson K., Olofsson H., Johansson S., and Melhus H. Association between oxidative stress and bone mineral density. Biochem. Biophys. Res. Commun. 288 (2001) 275-279
38. Steinbeck M.J., Appel Jr. W.H., Verhoeven A.J., and Karnovsky M.J. NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone. J. Cell Biol. 126 (1994) 765-772
39. Garrett I.R., Boyce B.F., Oreffo R.O., Bonewald L., Poser J., and Mundy G.R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J. Clin. Invest. 85 (1990) 632-639
40. Lean J.M., Davies J.T., Fuller K., Jagger C.J., Kirstein B., Partington G.A., et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J. Clin. Invest 112 (2003) 915-923
41. Lean J.M., Jagger C.J., Kirstein B., Fuller K., and Chambers T.J. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146 (2005) 728-735
42. Duranteau J., Chandel N.S., Kulisz A., Shao Z., and Schumacker P.T. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J. Biol. Chem. 273 (1998) 11619-11624
43. Dodd J.S., Raleigh J.A., and Gross T.S. Osteocyte hypoxia: a novel mechanotransduction pathway. Am. J. Physiol. 277 (1999) C598-C602
44. Zaman G., Pitsillides A.A., Rawlinson S.C., Suswillo R.F., Mosley J.R., Cheng M.Z., et al. Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes. J. Bone Miner. Res. 14 (1999) 1123-1131